LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.

MLA

Yang, Yiyi, et al. “LPS Priming before Plaque Deposition Impedes Microglial Activation and Restrains Aβ Pathology in the 5xFAD Mouse Model of Alzheimer’s Disease.” Brain, Behavior, and Immunity, vol. 113, Oct. 2023, pp. 228–47. EBSCOhost, https://doi.org/10.1016/j.bbi.2023.07.006.

APA

Yang, Y., García-Cruzado, M., Zeng, H., Camprubí-Ferrer, L., Bahatyrevich-Kharitonik, B., Bachiller, S., & Deierborg, T. (2023). LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer’s disease. Brain, Behavior, and Immunity, 113, 228–247. https://doi.org/10.1016/j.bbi.2023.07.006

Chicago

Yang, Yiyi, Marta García-Cruzado, Hairuo Zeng, Lluís Camprubí-Ferrer, Bazhena Bahatyrevich-Kharitonik, Sara Bachiller, and Tomas Deierborg. 2023. “LPS Priming before Plaque Deposition Impedes Microglial Activation and Restrains Aβ Pathology in the 5xFAD Mouse Model of Alzheimer’s Disease.” Brain, Behavior, and Immunity 113 (October): 228–47. doi:10.1016/j.bbi.2023.07.006.